Mitogenic signal transduction pathways in meningiomas: novel targets for meningioma chemotherapy?
about
AR42, a novel histone deacetylase inhibitor, as a potential therapy for vestibular schwannomas and meningiomas.EGFR, PIK3CA, KRAS and BRAF mutations in meningiomasGenetic/molecular alterations of meningiomas and the signaling pathways targeted.Novel therapies for meningiomas.Phase II trials of erlotinib or gefitinib in patients with recurrent meningioma.Treatment recommendations for primary extradural meningiomas.Medical treatment of recurrent meningiomas.Medical management of meningiomas.Activation of multiple growth factor signalling pathways is frequent in meningiomas.Cytotoxic effects of statins and thiazolidinediones on meningioma cells.STAT3 activation and risk of recurrence in meningiomas.Systemic therapy for recurrent meningioma.New drug candidates for treatment of atypical meningiomas: An integrated approach using gene expression signatures for drug repurposing.Cerebrospinal fluid stimulates leptomeningeal and meningioma cell proliferation and activation of STAT3.Bone morphogenetic protein 4 and its receptors are expressed in the leptomeninges and meningiomas and signal via the Smad pathway.A phase II trial of PTK787/ZK 222584 in recurrent or progressive radiation and surgery refractory meningiomas.Analysis of transforming growth factor β receptor expression and signaling in higher grade meningiomas.Emerging Medical Treatments for Meningioma in the Molecular Era
P2860
Q30464276-EA4AB66F-C8B3-4F7F-BDC6-1CE77541E8AAQ33727426-8A88A67D-CD86-4F73-AAFA-C674A6F37A89Q35793582-BF18C294-E2E0-46F4-B58F-6F0447DB9EE6Q36641500-6075B442-9C4D-42CC-BD1E-2764B35D739CQ37205309-7A1B00FA-00E7-4736-B4EF-04B3B273D9F3Q37786296-27047BA7-0828-49E5-8429-4A9B8AD91080Q37939997-C2BCB054-5439-4997-B858-4B708B9293A9Q38233448-C9C17F95-ED6F-4FAB-8708-B4730DF7AE4EQ38944293-858F1A48-E819-40A3-B5C5-8041D2BF57C7Q39661946-0BB5F24B-7B74-4F5A-9FCE-EBCC1AD60E7DQ41809124-011C0FFC-1340-4829-9002-511A0C3D1545Q48787594-3E158A91-0FC9-4210-A7F7-C7CF2B654A5EQ52646651-38EE03CD-A9DD-4825-9391-0034C7C52F31Q53214911-EEBF52C9-9E2D-46C7-AF8F-00EB9B16858FQ53366658-AE7A86A6-C2A3-47E1-8BDC-498FA0077B21Q54383059-93164610-5E53-4B32-9863-A0FDF6696623Q54410492-E273F323-7C95-479D-8DFC-086B21C9D46BQ58798211-19C0FF88-3754-4242-9DB3-571F9CC502F9
P2860
Mitogenic signal transduction pathways in meningiomas: novel targets for meningioma chemotherapy?
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Mitogenic signal transduction ...... s for meningioma chemotherapy?
@ast
Mitogenic signal transduction ...... s for meningioma chemotherapy?
@en
type
label
Mitogenic signal transduction ...... s for meningioma chemotherapy?
@ast
Mitogenic signal transduction ...... s for meningioma chemotherapy?
@en
prefLabel
Mitogenic signal transduction ...... s for meningioma chemotherapy?
@ast
Mitogenic signal transduction ...... s for meningioma chemotherapy?
@en
P2860
P1476
Mitogenic signal transduction ...... s for meningioma chemotherapy?
@en
P2093
Mahlon Johnson
Steven Toms
P2860
P304
P356
10.1097/01.JNEN.0000189834.63951.81
P577
2005-12-01T00:00:00Z